(untitled)
Stuart McPherson(Newcastle upon Tyne Hospitals NHS Foundation Trust), William Alazawi(Queen Mary University of London), Stephen T. Barclay(Glasgow Royal Infirmary), Emmanuel Tsochatzis(University College London), Prarthana Thiagarajan(Nottingham University Hospitals NHS Trust), Kate Hallsworth(Newcastle upon Tyne Hospitals NHS Foundation Trust), Paul Brennan(University of Dundee), Helen Jarvis(Newcastle University), Alexandra Thompson(Edinburgh Royal Infirmary), Ian Rowe(University of Leeds), Ashis Mukhopadhya(Aberdeen Royal Infirmary), Vanessa Hebditch, Matthew J. Armstrong(Queen Elizabeth University Hospital), Andrew D. Yeoman(Aneurin Bevan University Health Board), Richard Aspinall(Queen Alexandra Hospital), Richard Parker(Leeds Teaching Hospitals NHS Trust), Ankur Srivastava(North Bristol NHS Trust), Kathryn Jack(Nottingham University Hospitals NHS Trust), Robert Goldin(Imperial College London), Quentin M. Anstee(Newcastle upon Tyne Hospital), Jeremy Cobbold, Lynsey Corless(University of Hull), Jeremy Tomlinson(Oxford Centre for Diabetes, Endocrinology and Metabolism), Valerie Ross(Barts Health NHS Trust), Tessa Cacciottolo(National Institute for Health and Care Research), Wenhao Li(Barts Health NHS Trust), Jill L. Johnson(University of Idaho), Dina Mansour(Gateshead Health NHS Foundation Trust), Mary McCallum(University of Alberta)
Discovery Research Portal (University of Dundee)
August 1, 2022
Cited by 62
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k